Ferrigno Dean 4
4 · Sorrento Therapeutics, Inc. · Filed Feb 28, 2018
Insider Transaction Report
Form 4
Ferrigno Dean
Chief Accounting Officer
Transactions
- Other
Common Stock
2018-02-28+118→ 245 total
Footnotes (1)
- [F1]Pursuant to a stock purchase agreement by and among the Issuer, Scilex Pharmaceuticals Inc. ("Scilex"), the stockholders of Scilex party thereto and SPI Shareholders Representative, LLC, as representative of the Scilex Stockholders (the "Stock Purchase Agreement"), the Reporting Person sold 1,302 shares of common stock of Scilex to the Issuer and, upon the achievement of a milestone on February 28, 2018, the Issuer issued the Reporting Person 118 shares of the common stock of the Issuer. The Stock Purchase Agreement, which was entered into on November 8, 2016, placed a value on the Issuer's common stock of $9.95 per share. Contingent upon the achievement of such milestone, the Reporting Person's right to receive such shares became fixed and irrevocable on November 8, 2016.